Quick Takeaways
- Robert Lechleider has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $149,800.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robert Lechleider
- Location
- 665 Stockton Drive, Suite 300, PA
- Summary
- The estimated net worth of Robert Lechleider is at least $149,800 dollars as of 31 Jul 2025. Robert Lechleider is the Chief Medical Officer of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $149.8K.
- Signature
- /s/ Sandra Stoneman, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert Lechleider and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Immunome Inc. ($149,800).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Robert Lechleider
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMNM | Immunome Inc. | Chief Medical Officer | $149,800 | 29 Jul 2025 |
Insider Transactions Reported by Robert Lechleider:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.